Markets Edge

ReadingPE has identified healthcare infrastructure—not innovation—as the durable asset. Operators running standalone infusion networks are now operating on borrowed time.

ReadingHealthcare operators need to understand they are now competing with PE fund timelines, not market timing. The exit is no longer optional.

ReadingIf you own a PE-backed company and see secondary bids, you are in commoditization phase. The buyer is banking on your margins, not your roadmap.

ReadingBuilders locked into mid-market development now face a simple problem: their inventory is priced for last year's buyer. The new buyer already closed.

ReadingInstitutions are testing the bid, not committing. When the outflow reversal comes, it will happen on a single day with no warning.

ReadingEM is trading on narrative, not fundamentals. The next three months will separate which funds have real alpha from which have lucky timing.

ReadingIndian capital markets are confirming what global PE already knows: 2026 valuations are resetting. Every founder watching this IPO just learned their exit is worth less than they modeled.